Skip to main content
. Author manuscript; available in PMC: 2022 Jun 27.
Published in final edited form as: Mol Cancer Res. 2022 May 4;20(5):782–793. doi: 10.1158/1541-7786.MCR-21-1037

Figure 1.

Figure 1.

At week 12 after host castration, dormant prostate cancers were induced in PDXs. A, Percentage volumes of dormant (CX) PDXs at 12 weeks postcastration relative to the PDX volumes before host castration (mean ± SD = 11.65% ± 11.18%). B, Serum PSA of the hosts dropped to undetectable levels on day 84 (week 12) after castration. C, Representative images of H&E and IHC in precastration, dormancy, and relapsed prostate cancer PDXs. D, Ki-67 and caspase-3 (cleaved) percentages in precastration and dormant (at 12 weeks postcastration) PDXs. Casp-3, cleaved caspase-3.